ELEOPRA, ROBERTO

ELEOPRA, ROBERTO  

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale  

Mostra records
Risultati 1 - 20 di 43 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
STN-DBS and LCIG differentially affect long-term axial symptoms in Parkinson’s disease 2026 Eleopra, Roberto + Article (author) -
Neuroimaging and Pathology Biomarkers in Parkinson’s Disease and Parkinsonism 2026 Angelo Del SoleRoberto EleopraFabio Moda + Article (author) -
Up-regulation of tRNA-derived miR-1274b in tears of Parkinson's disease patients 2026 Eleopra, RobertoModa, Fabio + Article (author) -
Artificial Intelligence for STN-DBS Surgical Planning in Parkinson’s Disease: A Multicenter Study Comparing Conventional Targeting Versus Supervised Statistical Machine Learning 2026 Wu, FeifeiGiussani, Carlo GiorgioEleopra, Roberto + Article (author) -
Peripheral Biomarkers in α-Synucleinopathies: Unlocking Early Detection Through Olfactory Mucosa, Blood, and Urine Analysis 2025 Merve Begum BacınogluRoberto EleopraFabio Moda + Conference Object -
Detection of misfolded α-synuclein in the skin of patients with Parkinson’s disease and multiple system atrophy by seed amplification assay 2025 Merve Begum BacınogluRoberto EleopraFabio Moda + Conference Object -
α-Synuclein distribution in olfactory mucosa and skin nerves in Parkinson disease associated with an EIF4G1 gene mutation 2025 Moda, FabioEleopra, Roberto + Article (author) -
Exploring NEK1 genetic variability in Italian amyotrophic lateral sclerosis patients 2025 Pensato V.Peverelli S.Tiloca C.Pingue M.Manini A.Tannorella P.Doretti A.Terenghi F.Verde F.Eleopra R.Taroni F.Lauria Pinter G.Silani V.Ticozzi N.Ratti A. + Article (author) -
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study 2025 Percetti, MarcoPriori, AlbertoEleopra, Roberto + Article (author) -
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in Phase II Study on GBA-Associated Parkinson’s Disease Patients 2025 Fabio ModaPaola RotaRoberto Eleopra + Article (author) -
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 2025 Cocco A.Eleopra R.Monfrini E.Frattini E.Cogiamanian F.Arighi A.Cocco A.Boni L.Verde F.Triulzi F.Ticozzi N.Silani V.Ratti A.Poletti B.Caronni A.Baglio F.Moda F. + Article (author) -
Simultaneous MEG-LFP Recordings to Assess In Vivo Dystonic Neurophysiological Networks: A Feasibility Study 2025 Eleonora MinacapilliRoberto EleopraVincenzo Levi + Article (author) -
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 2025 Eleopra, RobertoDemartini, BenedettaNisticò, VeronicaEsposito, Marcello + Article (author) -
Chronic adaptive versus conventional deep brain stimulation in Parkinson’s disease: a blinded randomized pilot trial 2025 Isaias, Ioannis U.Marceglia, SaraBorellini, LindaMailland, EnricoCogiamanian, FilippoRemore, LuigiEleopra, RobertoLevi, VincenzoLocatelli, MarcoPriori, Alberto + Article (author) -
Dominant VPS16 Pathogenic Variants: Not Only Isolated Dystonia 2024 Monfrini, EdoardoBonato, GiuliaBrescia, GloriaCantarella, GiovannaReale, ChiaraEleopra, Roberto + Article (author) -
Neuroradiology: Focused ultrasound in neurosurgery 2024 Del Bene M.Eleopra R.Prada F.DiMeco F. Book Part (author) -
Elderly onset of functional motor disorders: clinical correlates from the Italian Registry 2024 Eleopra, RobertoDemartini, BenedettaGambini, Orsola + Article (author) -
Family History in Parkinson's Disease: A National Cross-Sectional Study 2024 Arienti, FedericaCasazza, GiovanniFranco, GiuliaLazzeri, GiuliaMonfrini, EdoardoDi Maio, AlessandroEleopra, Roberto + Article (author) -
Are patients with GBA–Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 2024 Eleopra, RobertoMonfrini, Edoardo + Article (author) -
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment inGBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 2023 Moda, FabioEleopra, Roberto + Article (author) -